| Identification | Back Directory | [Name]
2-(6-((2',6'-diMethyl-4'-(3-(Methylsulfonyl)propo
xy)-[1,1'-biphenyl]-3-yl)Me thoxy)-2,3- dihydro
benzofuran-3-yl)acetic acid | [CAS]
1390641-84-5 | [Synonyms]
rac-Fasiglifam (TAK-875)
3-Benzofuranacetic acid, 6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-
2-(6-((2',6'-diMethyl-4'-(3-(Methylsulfonyl)propo
xy)-[1,1'-biphenyl]-3-yl)Me thoxy)-2,3- dihydro
benzofuran-3-yl)acetic acid | [Molecular Formula]
C29H32O7S | [MDL Number]
MFCD27980564 | [MOL File]
1390641-84-5.mol | [Molecular Weight]
524.63 |
| Hazard Information | Back Directory | [Uses]
rac-TAK-875 is a potent, selective, and orally bioavailable GPR40 agonist. It also inspired the synthesis of the novel FFA1 agonist TUG-469 for the treatment of type 2 diabetes. |
|
| Company Name: |
T&W GROUP
|
| Telephone: |
021-61551611 13296011611 |
| Website: |
www.trustwe.com/ |
| Company Name: |
Energy Chemical
|
| Telephone: |
400-0056266 |
| Website: |
www.energy-chemical.com |
|